Innovations in Maternal, Neonatal, and Early Infancy Vaccines
Deadline Apr 30 2020 11:59 PM (EDT)
Description

Event Date: June 23, 2020
Deadline to Submit Abstracts: April 30, 2020

Maternal, neonatal, and early infancy vaccines have the potential to significantly improve the health of mothers and children worldwide by reducing morbidity and mortality from diseases that are a risk to individuals early in life, and for which no alternative effective preventive strategies exist.  Although several existing vaccines have been shown to be safe and effective for use during pregnancy, there are no vaccines formally approved or licensed specifically for use in pregnant women.  Active research is taking place, with substantial progress continually made.  It is believed that licensure of new vaccines exclusively for use in pregnant woman to protect their newborns and infants will soon be an attainable goal.

This one-day scientific symposium spans basic science, clinical, epidemiological, translational, and policy research, and will provide a neutral forum to explore recent achievements and challenges in the development and licensure of novel maternal vaccines, as well as the utilization of currently licensed vaccines during pregnancy.  Through a series of keynote and plenary presentations, major themes on the program include: maternal-fetal immunology and physiology; lessons learned from vaccines currently used in pregnancy; new targets for maternal, neonatal, and early infancy immunization; and maternal immunization barriers to uptake.

To register for this event, please visit the main website at: www.nyas.org/MaternalVaccines

Innovations in Maternal, Neonatal, and Early Infancy Vaccines


Event Date: June 23, 2020
Deadline to Submit Abstracts: April 30, 2020

Maternal, neonatal, and early infancy vaccines have the potential to significantly improve the health of mothers and children worldwide by reducing morbidity and mortality from diseases that are a risk to individuals early in life, and for which no alternative effective preventive strategies exist.  Although several existing vaccines have been shown to be safe and effective for use during pregnancy, there are no vaccines formally approved or licensed specifically for use in pregnant women.  Active research is taking place, with substantial progress continually made.  It is believed that licensure of new vaccines exclusively for use in pregnant woman to protect their newborns and infants will soon be an attainable goal.

This one-day scientific symposium spans basic science, clinical, epidemiological, translational, and policy research, and will provide a neutral forum to explore recent achievements and challenges in the development and licensure of novel maternal vaccines, as well as the utilization of currently licensed vaccines during pregnancy.  Through a series of keynote and plenary presentations, major themes on the program include: maternal-fetal immunology and physiology; lessons learned from vaccines currently used in pregnancy; new targets for maternal, neonatal, and early infancy immunization; and maternal immunization barriers to uptake.

To register for this event, please visit the main website at: www.nyas.org/MaternalVaccines

Deadline
Apr 30 2020 11:59 PM (EDT)